Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Carol Epstein, MD
MediVector, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
225 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Bedford Park, South Australia, Australia
- Facility name not stated
Deurne, Antwerpen, Belgium
- Facility name not stated
Brussels, Brussels Capital, Belgium
- Facility name not stated
Gozée, Hainaut, Belgium
- Facility name not stated
Mont-sur-Marchienne, Hainaut, Belgium
- Facility name not stated
Halen, Limburg, Belgium
- Facility name not stated
Ham, Limburg, Belgium
- Facility name not stated
Chenée, Liège, Belgium
- Facility name not stated
Deurne, Belgium
- Facility name not stated
Gribomont, Belgium
- Facility name not stated
Linkebeek, Belgium
- Facility name not stated
Gabrovo, Gabrovo, Bulgaria
- Facility name not stated
Haskovo, Haskovo, Bulgaria
- Facility name not stated
Plovdiv, Plovdiv, Bulgaria
- Facility name not stated
Smolyan, Smolyan, Bulgaria
- Facility name not stated
Sofia, Sofia-Grad, Bulgaria
- Facility name not stated
Varna, Varna, Bulgaria
- Facility name not stated
Veliko Tarnovo, Veliko Tarnovo, Bulgaria
- Facility name not stated
Burgas, Bulgaria
- Facility name not stated
Burgas, Bulgaria
- Facility name not stated
Gabrovo, Bulgaria
- Facility name not stated
Plovdiv, Bulgaria
- Facility name not stated
Plovdiv, Bulgaria
- Facility name not stated
Rousse, Bulgaria
- Facility name not stated
Rousse, Bulgaria
- Facility name not stated
Samokov, Bulgaria
- Facility name not stated
Sevlievo, Bulgaria
- Facility name not stated
Sliven, Bulgaria
- Facility name not stated
Smolyan, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Varna, Bulgaria
- Facility name not stated
Veliko Tarnovo, Bulgaria
- Facility name not stated
Balassagyarmat, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Csongrád, Hungary
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2014
- Primary completion
- 31 Mar 2015
- Completion
- 31 Mar 2015
- Last update posted
- 11 Nov 2015
- Registered enrollment
- 860
- Registry id
- NCT02026349
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.